Ovarian cancer is one of the deadliest gynaecological cancers, yet there currently is no early diagnostic test. Here’s what you need to know.

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Amy Van Wyk had a seizure while on holiday in South Africa and was given the devastating news her ovarian cancer had ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

PETALING JAYA: Health screenings which are both affordable and convenient encourage women to get regular check-ups. Senior ...

After battling ovarian cancer, Jennifer Garam found meaning in encouraging those facing serious illnesses to advocate for ...

The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

Three of the nine inspirational women, Debbie, Elaine and Dawn, who have taken part in a ground-breaking in podcast, Sex And ...

How a radical surgical approach saved the life of a neonatal nurse practitioner with a rare abdominal cancer - but meant ...

A Pap smear or Pap test is a screening test for cervical cancer. There’s currently no easy and reliable early screening test for ovarian cancer. A Pap smear or Pap test doesn’t help doctors ...

umontreal.ca Objectives To investigate employment in an occupation or industry and specific occupational exposures in relation to ovarian cancer risk. Methods In a population-based case–control study ...